Insider Trading History of Roberts Christopher D.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Roberts Christopher D. since 2020. This trader's CIK number is 1788368. At the time of last reporting, Roberts Christopher D. was the Chief Scientific Officer of Black Diamond Therapeutics, Inc.. (stock ticker symbol BDTX). Also see all insider trading activities at Black Diamond Therapeutics, Inc..


Yearly summary of insider trading at Black Diamond Therapeutics, Inc. (BDTX) by Roberts Christopher D.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 BDTX 0 $0 10,000 $271,601 10,000 $108,600
2020 BDTX 0 $0 15,000 $487,643 18,200 $197,652


Insider trading of Black Diamond Therapeutics, Inc. (BDTX) by Roberts Christopher D.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-04-05 BDTX Option Ex 2,500 10.86 27,150
2021-04-05 BDTX Sale 2,500 25.54 63,847
2021-03-03 BDTX Option Ex 2,500 10.86 27,150
2021-03-03 BDTX Sale 2,500 26.21 65,522
2021-02-03 BDTX Sale 2,500 25.35 63,375
2021-02-03 BDTX Option Ex 2,500 10.86 27,150
2021-01-04 BDTX Option Ex 2,500 10.86 27,150
2021-01-04 BDTX Sale 2,500 31.54 78,857
2020-12-15 BDTX Option Ex 3,200 10.86 34,752
2020-12-03 BDTX Option Ex 2,500 10.86 27,150
2020-12-03 BDTX Sale 2,500 32.42 81,054
2020-11-11 BDTX Option Ex 5,000 10.86 54,300
2020-11-11 BDTX Sale 5,000 34.90 174,500
2020-11-03 BDTX Option Ex 2,500 10.86 27,150
2020-11-03 BDTX Sale 2,500 31.95 79,872
2020-10-05 BDTX Option Ex 2,500 10.86 27,150
2020-10-05 BDTX Sale 2,500 31.59 78,987
2020-09-03 BDTX Option Ex 2,500 10.86 27,150
2020-09-03 BDTX Sale 2,500 29.29 73,230

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Roberts Christopher D. (Chief Scientific Officer of Black Diamond Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.